A key insight from the whitepaper is the increasing divergence in verification expectations between regions. While the EU ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

Despite the stigma, the coca plant is effectively entering the drug reform movement as part of an expected “third wave of decriminalization” along with other controlled substances including ...

Whilst carbon intensity is beginning to decline among the largest biotech and pharma companies, My Green Lab's 2025 Carbon ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.

Every few months, a new and unprecedented challenge threatens the global pharmaceutical supply chain. And while uncertainty affects all industries, the human cost of disruption in the drug supply ...

They may have started out by processing routine tasks for global majors, but Indian pharma GCCs have now become a magnet for talent and investment as tech advances throw up new opportunities. India is ...

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- On January 9th, GENEIII reaffirmed its global leadership in ergothioneine production ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

The MarketWatch News Department was not involved in the creation of this content. Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and ...